or inherited mutations can increase one's likelihood of experiencing severe symptoms. Due to this increased potential of contraction and subsequent severe symptoms, individuals with genetic conditions are among those with co-morbidities that have received cautionary advisories from the CDC and preferential designation for the rollout of COVID-19 vaccines. During the beginning months of the pandemic, existing legal protections, like GINA and the ADA, were put to the test. With scarce resources, including PPE, ventilators, and other crucial equipment, doctors and health care systems were put under incredible stress to treat an ever-increasing number of patients and in some places still continue to battle high numbers of cases. Due to the overwhelming surge in COVID-19 cases, hospital systems needed to enact triage protocols, or a system of guidelines meant to help direct resources and help health care professionals make choices about limited supplies. There were instances across the country early in the pandemic, where hospitals were accused of enacting discriminatory triage protocols which excluded those with genetic conditions, such as in Tennessee, where those with spinal muscular atrophy, a autosomal recessive disease, or other disabilities were prevented from receiving ventilators or other scarce resources. In other states for example, like Washington and Alabama, hospitals were accused of more broad discriminatory allocation policies which prevented larger groups of individuals with genetic conditions under categorizations of chronic conditions or intellectual disabilities from receiving life saving treatments, such as ventilators. Many advocacy groups raised complaints about these triage protocols to the Department of Health and Human Services Office of Civil Rights, and after the complaints the guidelines have been swiftly removed. These examples of triage protocols which had complaints raised against them are just a few of many across the country. These instances may now call into question the efficacy of current legal protections and their ability to prohibit genetic discrimination, opening up discussions of whether they might need to reformed in order to continue to protect individuals' genetic privacy and autonomy, but also to account for instances like a pandemic, where individuals with genetic conditions might be at greater risk. Further, the COVID-19 pandemic may have uncovered possible gaps among existent legal protections, like GINA, which may leave room for discrimination in longterm care and disability insurance, or the ADA, which more so covers ongoing disabilities, rather than susceptibility to conditions. Additionally conversations have turned to how to protect DNA and genetic privacy